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Summary 
The respiratory function and the antioxidant capacity of liver mitochondrial 
preparations i olated from Goto-Kakizaki non-insulin dependent diabetic rats and 
from Wistar control rats, with the age of 6 months, were compared. It was found that 
Goto-Kakizalci mitochondrial preparations presented a higher coupling between 
oxidative and phosphorylative systems, compared to non-diabetic preparations. 
Goto-Kakizaki mitochondria presented a lower susceptibility to lipid peroxidation 
induced by ADP/Fe2+ 3 as evaluated by the formation of thiobarbituric acid 
substances. The decreased susceptibility to peroxidation in diabetic rats was 
correlated with an increase in mitochondrial vitamin E (a-tocopherol) content and 
GSWGSSG ratio. Moreover, the glutathione reductase activity was significantly 
increased, whereas the glutathione peroxidase was decreased. Superoxide dismutase 
activity was unchanged in diabetic rats. Fatty acid analyses howed that the content in 
polyunsaturated fatty acids of Goto-Kakizaki mitochondrial membranes was 
significantly higher compared to controls. These results indicate that the lower 
susceptibility to lipid peroxidation of mitochondria from diabetic rats was related to 
their antioxidant defense systems, and may correspond to an adaptative response of 
the cells against oxidative stress in the early phase of diabetes. 
Key Words: Goto-Kakizaki rats, type 2 diabetes mellitus, mitochondria, respiratory index, lipid peroxidation, 
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Type 2 (non-insulin dependent) diabetes mellitus is one of the most common metabolic 
diseases in man, affecting about 100 million people around the world (about 3% of the human 
population) (1,2). 
Clinically, it is a heterogeneous di ease, characterized by a low glycaemic ontrol, due to 
impairment of the balance between R-cell secretion of insulin, peripheral insulin action and hepatic 
glucose production. However, it is still not clear which is the exact mechanism leading to increase 
of plasma glucose levels (3). 
Even being a disease with a high genetic susceptibility, other important risk factors are 
involved (as increased intake of sugars and lipids and decreased physical exercise), it becomes 
difficult to anticipate if a given individual will became diabetic. Thus, with the use of animal 
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models it became possible to predict the development of diabetes, and to distinguish the 
pathogenic mechanisms involved in the onset of the disease. Goto-Kakizaki rat (GK rat), a non- 
obese, spontaneously diabetic animal model (4) produced by repeated selective breeding of Wistar 
non-diabetic rats, and characterized by Goto and co-workers (5-7) is currently used as an animal 
model of type 2 diabetes mellitus. Until the age of 6 months GK rats exhibit a moderate but stable 
fasting hyperglycaemia (evident from 6 weeks of age), which does not progress to a ketotic state. 
Therefore, at the beginning of the diabetes, GK rats do not present severe complications 
associated to the disease, thus being an appropriate model to study the events at the onset of 
diabetes, as compared to genetically obese diabetic rats, which present severe hyperglycaemia and 
hyperlipidemia (8). 
Mitochondria re a major source of reactive oxygen species (ROS) within eucaryotic ells, 
due to energetic metabolism. These oxygen free radicals can react with cellular components, 
especially membrane lipids, producing cell damage (9). Under normal conditions, potentially toxic 
ROS generated by mitochondrial respiratory metabolism are efficiently neutralized by cellular 
antioxidant defense mechanisms. However, this balance can easily be broken, leading to cellular 
dysfunction (lo- 12). This imbalance between pro- and antioxidant systems is very important in 
many disease processes, including diabetes mellitus, and is probably related to the complications 
associated tothe disease (13). 
The mitochondrial respiratory chain activities coupled to oxidative phosphorylation and 
compartment&ion f energy-rich metabolites (ATP, CrP) at sites of cell specific function, are 
some of the fundamental spects of glucose metabolism (for review see 14). In fact, it has been 
shown that in streptozotocin-induced diabetic rats, the mitochondrial dysfunction may contribute 
to diabetes-associated pathology (15, 16). However, at present little is known about 
mitochondrial function in non-insulin dependent diabetes mellitus. 
In order to clarify the role of the antioxidant systems in type 2 diabetes, we investigated the 
possible alterations in GK mitochondrial lipid peroxidation, the fatty acid composition and 
antioxidant systems of liver mitochondria solated from rats of about 6 months (26 weeks) of age. 
In addition, we determined also the effect of diabetes on the mitochondrial respiratory control 
ratio (RCR) and ADP/O. We found that diabetic GK rats present a higher content of unsaturated 
fatty acids as compared to non-diabetic rats. However, our results indicate that GK rats 
mitochondrial induced lipid peroxidation is decreased, suggesting the existence of a higher 
antioxidant capacity in diabetic rats. 
Materials and Methods 
Animals: Male spontaneously diabetic GK rats were obtained from a local breeding colony 
(Animal Research Center Laboratory, University Hospitals, Coimbra), established in 1995 with 
breeding couples from the colony at the Tohoku University School of Medicine (Sendai, Japan; 
courtesy of Dr. K.I. Susuki). Control animals were non-diabetic male Wistar rats of similar age, 
obtained from our local colony (Animal Research Center Laboratory, University Hospitals, 
Coimbra). Animals were kept under controlled light and humidity conditions and with free access 
to powdered rodent chow (diet C.R.F. 20, Charles Rivers, France) and water. Glucose tolerance 
tests were used as a selection index. 
Materials: All reagents and chemicals used were of the highest grade of purity commercially 
available. 
Preparation of Mitochondria: Wistar and GK rats were maintained ad lib&urn for at least 12 
hours, before being sacrificed for cervical displacement, according to a preestablished method (17), 
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with slight modifications ( 18). 
Protein was determined by the Bradford method, using BSA (bovine serum albumin) as a standard 
(19,20). 
Blood Glucose and HbA]c Levels Determination: Blood glucose levels were determined, 
immediately after animals’ sacrifice, through the glucose oxidase reaction, using a glucometer 
(Glucometer Elite, Bayer, Portugal S.A.) and compatible reactive tests. HbAlc levels were 
determined through ionic exchange chromatographic assay (Abbott IMx Glicohemoglobina, 
Abbott Laboratories, Portugal). 
Determination of Thiobarbituric Acid Reactive Substances: Lipid peroxidation was measured as 
thiobarbituric acid-reactive products, as described previously (2 I), with slight modifications. To 
induce lipid peroxidation, mitochondria (1 mg) were incubated in 1 ml of reaction medium (150 
mM KC1 and 25 mM Tris-Cl, pH 7.2), in the presence of 1 mM ADP and 0.1 mM Fe*+ (22), at 
30 “C during 20 min. with continuous tirring. The reaction was stopped by lowering the 
temperature to O-4 “C by placing the tubes on ice. To measure the extent of lipid peroxidation, 0.5 
ml of cold 40% TCA and 0.67 % TBA was added to 0.5 ml of sample material and the tubes were 
treated for 15 min. in a boiling water bath. The tubes were allowed to cool at room temperature 
and centrifuged at 3000 rpm for 10 min.. The supematant was collected and the absorbance was 
measured at 530 nm in a Bausch & Lomb Spectronic 21. The amount of malonyldialdehyde 
(MDA) formed was calculated using a molar extinction coefficient of 1.56 x lo5 cm-‘.min-’ and 
expressed as nmol MDA/mg protein (23). 
Fatty AcidAnalysis: 1 ml of homogenate was extracted according to Bligh and Dyer (24) and the 
chloroform phase was dried under a stream of N2. The preparation of fatty acid methyl esters 
(FAME) was performed according to Madeira and Antunes-Madeira (25) using 5 % sulfuric acid 
in methanoI as the derivatizing reagent. The FAME analysis was performed using a Varian 
Aerograph series 2700 gas chromatograph, adapted for capillary columns, with nitrogen as the 
carrier gas. The column used was a SGE glass capillary column (25QC5BPX70 0.5) and the 
temperature program was the following: 5 min. at 140 “C; 4 “Urnin. to 210 “C; 10 min. at the 
upper temperature. The results were calculated using a Milton Roy U-4 100 integrator. 
Determination of Vitamin E Content in Mitochondrlat Membranes: The extraction and separation 
of membrane vitamin E (a-tocopherol) was performed by following the methods described 
previously (26-28). 1.5 ml SDS 10 mM were added to 2 mg mitochondrial protein, followed by 
addition of 2 ml of absolute thanol. Then, 2 ml of n-hexane and 50 ml of KC1 3 M was added 
and the mixture was vortexed for about 3 min.. The extract was centrifuged at 2000 rpm, for 3 
min., to allow for phase separation. One ml of the upper phase containing n-hexane (n-hexane 
layer) was recovered and evaporated to dryness under a stream of N2, and kept at -80 ‘C, until 
further use. The extract was redissolved in n-hexane and vitamin E content was analyzed by 
reverse phase HPLC. A 4.6 x 200 mm Spherisorb Slow column was eluted with n-hexane 
modified with 0.9 % methanol, at a flow of 1.5 ml/ min. Detection was performed by a UV 
detector, at 287 nm. 
Reduced (GSH) and Oxidized (GSSG) Glutafhione Measurements In Mitochondria: GSH and 
GSSG levels were determined with fluorescence detection after reaction of the supematant of the 
H3POJ EDTA-NaHZP04 deproteinized mitochondria solution with the reagent o-phthalaldeyde, 
at pH 8.0, according to Hissin and Hilf (29). 
Enzymatic Assays: Glutathione peroxidase was assayed by the method of Flohe and Gunzler (30). 
The activity of the enzyme was measured indirectly by determining the oxidation of NADPH, at 
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340 nm, induced by the action of glutathione peroxidase. Reaction mixtures contained 50 mM 
potassium phosphate (pH 7.0), 0.5 mM EDTA, 1 mM GSH, 0.24 U glutathione reductase and 
0.1 mg of mitochondrial sample. The reaction, performed at 30 “C, was initiated by the addition 
of 0.15 mM NADPH. At 3 min, 1.2 mM t-butyl hydroperoxide was added and the absorvencies 
recorded for 5 min. Results are expressed as umol GSH oxidized.min-1 per mg protein. 
The glutathione reductase was assayed by followmg the oxidation of NADPH at 340 nm (3 1). 
Reaction mixtures contained 100 mM potassium phosphate (pH 7.4), 1 mM EDTA, 0.15 mM 
NADPH and about 0.1 mg protein. The reaction was initiated by the addition of 1 mM GSSG. 
Results are expressed as umol NADPH oxidized min-I per mg protein. 
Superoxide dismutase (MnSOD) was determined by inhibition of the reduction rate of nitroblue 
tetrazolium (NBT), monitored at 550 mm using xanthine-xanthine oxidase system (32). Reaction 
mixtures contained 50 mM potassium phosphate (pH 7.4), 1 mM EDTA, 100 uM NBT, Triton 
X-100 (0.025%, v/v), 2 mM KCN and hipoxanthine 100 uM. The reaction was initiated by the 
addition of xanthine oxidase 0.025 U/ml. One unit of activity is defined as that amount of enzyme 
which inhibits the reduction rate of NBT by 50%. 
Mitochondriai Resprration: Oxygen consumption of isolated mitochondria was determined 
polarographically at 25 “C with a Clark oxygen electrode, connected to a suitable recorder in a 
closed chamber with magnetic stirring. Mitochondria (1 mg) and respiratory substrates (glutamate 
+ maiate or succinate) were added to the standard reaction medium (1 ml), and additionally, when 
succinate was used, 2 uM of rotenone were added to the medium. To induce state 3 respiration, 
300-400 nmol of ADP were used. The respiratory control ratio (RCR) and ADPi ratios were 
calculated according to Chance and Williams (33). 
Statistics: The results are presented as mean f SEM of the indicated number of experiments and 
statistical significance was determined using paired Student’s t-test or one-way analysis of 
variance (ANOVA). 
Results 
A. Characterization oj”Animals 
At 6 month’s, GK rats body weights were significantly lower than those of Wistar rats. 
Blocd glucose and glycated hemoglobin (HbAlc, which gives the mean values of giycaemias of the 
previous 2 months) are significantly increased as compared to control (Table 1). 
B. Studies of Respiratory Indexes qf GK and W&tar I,wer Mitochondrra 
Respiratory control ratios (RCR) were determined in the presence of a FAD-linked substrate 
(succinate) and a NAD-linked substrate (glutamate + malate). In the presence of both respiratory 
substrates, GK rats RCR are increased as compared to Wistar rats (Figure l), since State 3 
respiration is increased in GK rats (Table 2). 
ADP/O ratios were evaluated in the presence of succinate as an oxidable substrate (Figure 2). The 
ADP/O ratio represents the coupling between the ADP phosphorylation and oxygen utilization, 
and therefore can be used to estimate the approximate quantity of oxygen used by the respiratory 
chain, but not to phosphorylate ADP. We found that ADP/O ratios of GK rats are increased as 
compared to control rats. 
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Table 1. Characterization f GK and Wistar ats with 26 weeks of age 
Condition Wistar GK 
Body Weight 523 f 11.7 369 f 4.9 * 
(p) (n=6) (n=9) 
Glycaem ia 103.3 + 4.53 184.2 f 15.50 * 
(mgAl) (n=14) (n=13) 
m&c 5.1 * 0.16 10.4 f 0.56 ** 
% (n=4) (n=4) 
Data are mean f SEM of the number of animals indicated on the table. Glycaemia was determined by glucose 
oxidase reaction (Glucometer Elite, Bayer, Portugal S.A.). HbAlc (%) was determined through ionic change 
chromatographic assay (Abbott IMx Glicohemoglobina kit). Values statistically different from control: * p < 
0.005; ** p< 0.0005. 
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69 GK 
Succiaate Glutamate+Malate 
Fig. 1 
Respiratory control ratio (RCR) of GK and Wistar rats, determined in the presence of 
succinate and glutamate + malate as oxidizable substrates. To induce state 3 respiration, 
300-400 nmol ADP were used Data are mean & SEM of lo-12 independent experiments. 
Values statistically different from control: * p < 0.05. 
C. Fatty Acid Composition of Liver Mitochondria Isolatedfiom GK ana’ Wistar Rats 
The fatty acid composition of mitochondrial membranes was evaluated (Figure 3 and Table 3). 
We observe that GK rats mitochondrial membranes present a higher content of unsaturated long 
chain fatty acids (namely arachidonic (20:4) and docosohexanoic (22:6) acids) with a marked 
decrease in saturated fatty acids (palmitic (16:O) and stearic (18:O) acids). 
We also observe amarked increase in the ratio between unsaturated and saturated fatty acids (up 
to 67 %) and in unsaturation i dex (up to 51 %) in GK mitochondrial preparations. Our results 
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indicate also a small increase of average chain length (up to 4%) in diabetic rats. 
Table 2. GK diabetic and Wistar rats State 4 and State 3 respiration 
Condition 
Glutamate + malate 
State 4 respiration 
(urn01 O/min/mg protein) 
State 3 respiration 
(nmol O/min/mg protein) 
Wistar 
14.7 f 1.05 
(n=12) 
72.7 f 7.06 
(n=12) 
GK 
14.5 St 0.75 
(n=12) 
91.1 * 4.54 ** 
(n=12) 
Succinate 
State 4 respiration 32.6 * 2.57 31.3 l 2.57 
(nmol O/min/mg protein) (n=lO) (n=lO) 
State 3 respiration 148.3 f 7.14 175.8 f 11.35 ** 
(nmol O/min/mg protein) (n=lO) (n=lO) 
State 4 and State 3 respiration determined in the presence of glutamate+malate nd succinate as respiratory 
substrates To induce state 3 respiration, 300 nmol ADP were used. Data are mean f SEM of the indicated number 
of independent experiments. Values statistically different from control: ** p < 0.005 
ADP/O 
ratio 
1.8 
1.6 
Wistar GK 
Fig. 2 
ADP/O ratio of GK and Wistar rats, determined inthe presence of succinate as a respiratory 
substrate. To induce state 3 respiration, 300 nmol ADP were used. Data are mean * SEM of 
10 independent experiments. Values statistically different from control: ** p < 0.005. 
D. Susceptibility to Lipid Peroxidation of Mitochondrial Preparations from GK and Wistar Rats 
Lipid peroxidation was assessed with thiobarbituric acid-reacting substances (TBARS) assay and 
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was expressed as nmol MDA/ mg protein, 
Table 3. GK diabetic and Wistar rats mitochondrial fatty acid composition determined 
by GLC analysis 
property 
Unsaturation index 
Average chain length 
Wistar 
119.71 f 4.67 
17.69 f 0.06 
GK 
181.5 f 14.09 
18.32 f 0.14 
% saturates 54.76 f 1.24 42.03 f 2.49 
% unsaturates 45.24 f 1.24 57.97 f 2.49 
% monounsaturates 12.06 f 0.14 11.18* 0.23 
% polyunsaturates 33.19 f 1.09 47.79 f 2.72 
unsaturates I saturates 0.83 f 0.04 1.39kO.14 
The results are the mean f SEM for 4 separate analysis. The unsaturation i dex expresses the number of double 
bonds per 100 fatty acid molecules. Average chain length is S(chain length x mole W) of individual species (38). All 
data from GK preparations were significantly different from control (pc 0.05). 
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Fig. 3 
Cl Wistar 
H GK 
Fatty acid composition of GK and Wistar mitochondrial membranes, determined by GLC 
(gas-liquid chromatography) analysis. Data are mean f SEM of 4 separate analysis (either 
GK and Wistar rats). The data given for the fatty acid analysis does not include minor 
components, which constitute less than 6 % of the total fatty acid content. When error bars 
are absent, SEM is encompassed by the size of the symbols. Values statistically different 
from control: * p < 0.05; ** p < 0.005. 
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Initial levels of TBARS (Figure 4) were the same in liver mitochondrial preparations isolated from 
GK and control rats (0.94 * 0.148 and 1.09 + 0.201 nmol MDA/ mg protein, respectively). 
However, the preparations from liver of diabetic GK rats were less susceptible to induced lipid 
peroxidation (using ADP + Fe*+ as peroxidation i ducer), as compared to control (12.1 f 2.42 and 
16.5 i 1.67 run01 MDA/ mg protein, respectively in GK and Wistar rats). 
nmolMDA/ 10 
mg protein 
0 
Control Peroxidized 
Fig. 4 
Lipid peroxidation of GK and Wistar mitochondrial membranes, evaluated from TBARS 
(thiobarbituric acid-reactive species) production. In the absence of peroxidation inducer 
(ADP/ Fe*+), TBARS production of Wistar and GK preparations are similar. However, in 
the presence of (ADP/ Fe*+), lipid peroxidation is lower in GK rats. Data are mean f SEM 
of 7 independent experiments. Values statistically different from control: * p < 0.05. 
These results were unexpected, since the amount of unsaturated fatty acids is largely increased in 
diabetic GK rats. Thus, it seems acceptable to us that diabetic GK rats antioxidant capacity is 
enhanced as compared to normal rats. 
LT. Mitochondrial a-tocopherol Levels 
We found that the lower susceptibility to lipid peroxidation of GK liver mitochondrial 
preparations was correlated with the increased vitamin E (a-tocopherol) contents of diabetic rats 
(2.28 f 0.550 versus 4.29 f 0.858 nmol a-tocopherol/ mg protein, respectively in Wistar and GK 
rats) (Figure 5). 
F. Mitochondrral GSH/GSSG Ratio and Antioxrdant Enzyme Activities in GK and Wistar Rats 
Since glutathione in the reduced form (GSH) is known to play an important role in protecting 
cells (and organelles) from oxidative stress, GSH/GSSG ratios were evaluated both in GK and 
Wistar mitochondrial preparations (Figure 6). We found that GSWGSSG ratio is higher in kGK 
diabetic rats (up to 40 %) compared to Wistar animals Thus, our results point to a higher 
antioxidant capacity of GK rats as compared to normal rats. 
Table 4 shows the activity of the antioxidant enzymes in liver mitochondrial preparations of 
normal Wistar and diabetic GK rats. As can be observed, MnSOD levels were not altered by 
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Vitamin E 
(nmol/ mg 
content 
protein) 
Wistar GK 
Fig. 5 
Vitamin E (a-tocopherol) content of GK and Wistar mitochondrial preparations, evaluated 
by HPLC (high pressure liquid chromatography) analysis. Data are mean f SEM of 5 
independent experiments. Values statistically different from control: * p < 0.05. 
GSH/GSSG 
ratio 
1.0 
0.8 
0.6 
i 
0.4 
0.2 
0.0 
WiStar GK 
Fig. 6 
Glutathione status of GK and Wistar mitochondrial preparations. GSH and GSSG levels 
were determined with fluorescence detection. GSH levels were 7.9 A 0.25 and 12.2 + 0.4 
nmol/mg protein, while GSSG levels were 19.75 f 0.5 and 15.8 f 0.75 nmol/mg protein, 
respectively in Wistar and GK preparations. Data are mean f SEM of 5 independent 
experiments (Wistar and GK rats). Values statistically different from control: * p < 0.05. 
diabetes. Glutathione reductase activity increased significantly (p<O.OS) in mitochondria of 
diabetic GK rats (22.61 f 1.15 umol NADPH/min/mg protein) as compared with normal animals 
(17.19 f 0.46 umol NADPH/min/mg protein). Glutathione peroxidase activity was significantly 
decreased (p<O.OS) in diabetic animals from 148.95 f 9.1 to 117.94 f 7.87 umol GSWminImg 
protein, respectively in control Wistar and diabetic GK rats. 
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Table 4. Activities of mitochondrial glutathione reductase, glutathione 
peroxidase and superoxide dismutase in the liver from GK diabetic and Wistar rats. 
Enzyme 
GSSG reductase 
Wistar 
17.19+0.46 
GK 
22.62 l 1.15 * 
GSH peroxidase 148.95 f 9.10 117.94 f 7.87 * 
Superoxide dismutase 3.73 f 0.12 3.84 f 0.13 
The activity of GSSG reductase was expressed in pmol NADPH oxidiied.min-1 per mg protein and the activity 
of GSH peroxidase in pmol GSH oxidized min- 1 per mg protein. Superoxide dismutase activity was expressed in 
units per mg protein. The results are the mean f SEM for 4 different preparations. Values statistically different from 
control: * p< 0.05. 
Discussion 
Type 2 diabetes mellitus is a heterogeneous disease, characterized by low blood glucose control 
(intolerance to glucose) and results either from resistance toglucose in peripheral tissues (skeletal 
muscle and adipocytes) and/or a relative decrease of g-cell activity (34). Depending on several 
factors (obesity, age of onset, severity of glucose intolerance, and mode of inheritance), clinical 
features of individuals uffering from type 2 diabetes mellitus are highly variable (35). 
Due to constant hyperglycaemic levels, type 2 diabetes mellitus patients are exposed to an 
increased oxidative stress (12), since the production of several reducing sugars (through glycolysis 
and polyol pathways) isenhanced. These reducing sugars can easily react with lipids and proteins 
(nonenzymatic glycation reaction) (3) increasing the production of ROS (36). 
In fact, our results indicate a significant increase in glycated hemoglobin (HbAlc) of GK rats. 
This parameter isextremely useful in clinical trials, since it becomes possible to estimate the mean 
values of glycaemia during the last two months before the analysis. Thus, our results indicate 
mean values of glycaemia (extrapolated from HbA 1~ values) of 92 and 250 mg glucose/ dl blood, 
respectively in control and in GK diabetic rats. As a result, GK rats were undoubtedly exposed to 
a marked oxidative stress, as shown by the mean values of glycaemia. 
The increased production of ROS could be reelected in mitochondrial membrane fatty acid 
composition. Nevertheless, analyses of fatty acid composition of liver mitochondria show a 
higher content of polyunsaturated long chain fatty acids (namely arachidonic and docosohexanoic 
acids) and a marked ecrease in saturated fatty acids (palmitic and stearic acids) in GK diabetic 
rats as compared to Wistar non-diabetic rats. Consequently, we observed an increase in the 
unsaturation i dex (which reflects the average number of unsaturations per 100 C-C bonds), and a 
marked increase (up to 67 Oh) in the ratio between the contents of unsaturated/saturated fatty 
acids in GK rats. Our analyses also indicate an increase in fatty acids average length chain in the 
GK preparations. 
Interestingly, studies of susceptibility of liver mitochondrial preparations to lipid peroxidation in 
vitro (evaluated by TF3ARS formation), showed that GK mitochondrial preparations were less 
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susceptible to lipid peroxidation than control preparations. These results are in agreement with 
the observations of Kristal et al. (15) and Sukalski ef al. (37) using mitochondria of 
streptozotocin-induced diabetic rats, with brief periods of induced diabetes duration. Also, these 
results could indicate a decrease in susceptibility of induction to lipid peroxidation i  vivo in GK 
rats, since the content in polyunsaturated fatty acids is significantly higher than in Wistar non- 
diabetic rats. 
We found that GK mitochondrial preparations were less susceptible to in vitro oxidation, 
evaluated both by TBARS formation and 02 consumption (data not shown). This lower 
susceptibility of GK mitochondrial preparations to induced oxidation is correlated with an 
increase in mitochondrial vitamin E (a-tocopherol) content. It is well known that vitamin E is one 
of the major lipid soluble chain-breaking antioxidants hat can prevent he propagation of lipid 
peroxidation chain reaction, by scavenging lipid peroxyl radicals (38, 39). Therefore, despite the 
increase in ROS production due to hyperglycemic condition, the increase in a-tocopherol content 
in liver mitochondrial membranes of diabetic GK rats is consistent with the lower lipid 
peroxidation levels observed. These results, as the results described by Sukalski et al. (37), point 
to alterations in metabolism (or storage) of a-tocopherol in GK diabetic rats as compared to 
Wistar rats. 
Our studies indicate that GK liver mitochondria respiratory indexes (RCR and ADP/O) were 
enhanced, compared to control rats. The observed enhanced phosphorylative efficiency can also 
be correlated with the larger concentration f a-tocopherol, since vitamin E is reported to interact 
with the early parts of respiratory chain, protecting the thiol groups of proteins from oxidative 
stress. Moreover, it seems that a-tocopherol interacts with ubiquinone (Qio) in the reduced form 
(ubiquinol), acomponent ofmitochondrial redox chain with antioxidant capacity. This antioxidant 
effect of ubiquinol seems to be due to its capacity of regenerating oxidized a-tocopherol (40). 
Furthermore, a higher coupling between oxidative and phosphorylative systems generates an 
increased ROS production (41). Therefore, the increased efficiency of phosphorylative oxidation 
in GK rats can be correlated with the higher concentration f a-tocopherol in GK membranes. 
Studies of glutathione content were also performed in mitochondrial diabetic and control 
preparations, since intracellular GSH plays an important role in the metabolism of 
hydroperoxydes and free radicals (42). Moreover, GSH plays a crucial role in mitochondrial 
function, since mitochondria l ck catalase, and therefore peroxides are reduced only by ghrtathione 
peroxidase. During this reaction GSH is oxidized and glutathione disulfide (GSSG) is formed 
Most of GSSG formed in glut&one peroxidase catalyzed reactions is subsequently reduced by 
glutathione r ductase, an important antioxidant enzyme. So, GSWGSSG ratio may be regarded as 
a measure of the antioxidant capacity of biological systems (43, 44). The observation that 
GSWGSSG ratio is higher in GK preparations uggest hat GSH could protect diabetic 
mitochondria from damage mediated by free radicals. To clarify the reasons why reduced 
glutathione isincreased in mitochondria solated from diabetic rats we measured also the activities 
of glutathione reductase and glutathione peroxidase. Both the enzymes are involved in the redox 
cycling of glutathione. Glutathione peroxidase by removing hydrogen peroxides and lipid 
peroxides (30) and glutathione reductase by restoring reduced glutathione maintaining the 
intracellular GSH concentration (31). In our study, glutathione r ductase activity was found to be 
increased whereas glutathione peroxidase activity was decreased. Our fmdings related to 
glutathione are in contradiction with the results published by Sukalski et al. (37) who reported 
that liver mitochondria solated from diabetic animals had lower levels of gluthathione r ductase, 
glutathione peroxidase and SOD than mitochondria solated from control animals. However, it is 
important to refer that the published values are from mitochondria isolated from streptozotocin- 
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treated rats, a model of insulin-dependent diabetes mellitus. More recently, Kristal et al. (15) have 
found that SOD activity did not changed while glutathione peroxidase levels were reduced by 
diabetes induced by streptozotocin. 
The increase in glutathione reductase activity may be the reason why glutathione level increase in 
diabetic mitochondria and could represent a compensatory mechanism of mitochondria in order to 
maintain higher levels of glutathione. The increase concentration of mitochondrial glutathione may 
contribute to mitochondrial protection by decreasing the susceptibility of diabetic mitochondria 
against reactive oxygen intermediates and free radicals and by increasing antioxidant defenses (45). 
The decrease in glutathione peroxidase activity may reflect the utilization of this enzyme by 
oxygen free radicals generated uring diabetes. 
In conclusion, we found that, at the age of 6 months, diabetic GK mitochondrial preparations 
present a higher coupling between oxidative and phosphorylative systems as compared to control 
preparations. Moreover, our results indicate that the lower susceptibility to lipid peroxidation of 
mitochondria from diabetic rats was related to their antioxidant defense mechanisms. 
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